Regenera Global Announces Bahamas Conference Where Esteemed Global Thought-Leaders Present New Archetype for Practicing Regenerative Medicine

At the "Regenerative Medicine 2.0: Redefining the Practice" Conference, Speakers Discuss Ground-Breaking Stem Cell and Gene Therapy, Organ and Tissue Engineering and Innovative Biotechnology Currently Available for Patients

(PRWEB) April 13, 2016

Regenera Global, Inc.in partnership with the Grand Bahama Port Authority announces that it will host the "Regenerative Medicine 2.0: Redefining the Practice" Conference June 23-25 at the Grand Lucayan in Freeport, Grand Bahama. Globally esteemed speakers will demonstrate new concepts and regenerative medicine approaches to harness the human body's inherent healing mechanism for better patient outcomes. The conference will bring together scientists, clinicians, patients, medical device manufacturers and industry stakeholders within the regenerative medicine field to promote the clinical translation of evidence-based science. Industry participants will be present to demonstrate their products and services to those in attendance.

Luis Martinez, M.D., CEO of Regenera Global, Inc., states, "We are excited about this inaugural, one of a kind conference which will define current and future trends in the field of Regenerative Medicine. Additionally, our collaboration with the Grand Bahama Port Authority has reaffirmed the interest and commitment to establish the Bahamas as a world leader in this innovative field of Medicine." Dr. Martinez will discuss "Gene Therapy for Peripheral Artery Disease" at the Conference and will speak throughout the event about why the industry needs to redefine the Practice of Regenerative Medicine.

Doris Taylor, Ph.D., FACC, FAHA, Research Director at the Texas Heart Institute, will discuss the development of better treatments for heart disease, including the building of bio-artificial organs for transplant that use a patient's own stem cells, thus avoiding the complications of organ rejection.

Michael Fossel, M.D., Ph.D., Founder and former editor-in-chief of Rejuvenation Research, is a professor of clinical medicine who will teach a workshop on the Biology of Aging and present "Telomerase therapeutics: Curing age-related disease and resetting cell aging" on Friday, June 24's General Session.

Activities will include several workshops including the "Fundamentals of Telomere Biology: Principles and Applications" by Michael Fossel, MD, PhD, the "Producing a Standardized and Therapeutic Product Workshop, a cardiovascular cell therapy demonstration, network receptions and a tour of a center of excellence, Okyanos Cell Therapy. Additional activities are planned for conference attendees, and the agenda may be viewed at RegeneraGlobal.com. All are welcome to register and attend with the information provided at http://regeneraglobal.com.

About Regenera Global, Inc.

Based in Puerto Rico, Regenera Global, Inc. is a bio-technology firm focused on developing and commercializing innovative therapies, providing consulting services and educational events to physicians and healthcare practitioners to expand their knowledge of regenerative medicine clinical applications which may include, but is not limited to, stem cell and gene therapy, tissue engineering, and select medical devices. Regenera Global is working to bridge the gap of access to regenerative medicine between the progress made through research and what is available clinically to physicians and patients.

Twitter:     https://twitter.com/RegeneraGlobal
LinkedIn: https://www.linkedin.com/company/regenera-global?trk=biz-companies-cym
Google+: https://plus.google.com/117977749219422536232?hl=en
Facebook: https://www.facebook.com/RegeneraGlobal/

For the original version on PRWeb visit: http://www.prweb.com/releases/2016/04/prweb13334472.htm